Post-marketing surveillance of StrataCTX® flexible wound dressing for use as a steroid sparing agent

To assess the use of StrataCTX® as a steroid sparing agent for disorders usually treated with topical steroids.

Are you Eligible? (Inclusion Criteria)

• Age ≥ 18 years
• Ability to sign informed consent document
• Patient with a diagnosis of CTCL who have contact dermatitis to topical
• mechlorethamine gel
• Patients with a diagnosis of CTCL who have intractable pruritus
• Patients with a diagnosis of CTCL who rely heavily on topical steroids for
• symptomatic relief
• Patients on chemo/immunotherapy with drug induced rash
• Patients with cutaneous acute graft versus host disease